PATENT CLAIM ANALYSIS

Application Number: 16200508
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "044000"]

Abstract:
Treatment of tumors, especially breast cancer or glioblastoma tumors, by silencing RAB27A and/or TRAF3IP2, compositions and methods for same.

Claim (Index 1):
A pharmaceutical composition for the treatment of a tumor having increased expression of TRAF3IP2, wherein said composition comprises at least one silencing sequence for TRAF3IP2 in a pharmaceutically acceptable carrier in an amount effective for the therapeutic treatment of a tumor, wherein said silencing sequence reduces the expression of the TRAF3IP2 gene by at least two-fold as comparing to without the silencing sequence for TRAF3IP2, and wherein said silencing sequence is a modified portion of sense strand of NM_001164281.2 (SEQ ID NO. 7), NM_147200.2 (SEQ ID NO. 8), XM_011535386.2 (SEQ ID NO. 9), NM_147686.3 (SEQ ID NO. 10), XM006715319.4 (SEQ ID NO. 11), and NM_001164283.2. (SEQ ID NO. 12).

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14814130', '12792413', '14367926', '14239120', '14919448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7100266147288474
- 35 USC 102 Novelty (BERT): 0.6645082561232921
- Combined Prediction Score: 0.7054747788682919
- Mean Citation Score: 351.342546
- Max Citation Score: 704.4082599999997
- Similarity Product: 590.8454817501388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test